What is new in the 2021 ESC HF guidelines regarding patients with EF>40%? - PACE-CME

What is new in the ESC HF guidelines regarding patients with EF

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Implementation of salt substitution strategies
Implementation of salt substitution strategies
ESC 2021
Implementation of salt substitution strategies
- Prof. Barbara Casadei, MD
Surgery vs. stenting with asymptomatic critical carotid artery stenosis
Surgery vs. stenting with asymptomatic critical carotid artery stenosis
ESC 2021
Surgery vs. stenting with asymptomatic critical carotid artery stenosis
- Prof. Freek Verheugt, MD
Moving the field of medicine and science is a collective exercise
Moving the field of medicine and science is a collective exercise
ESC 2021
Moving the field of medicine and science is a collective exercise
- Prof. Stephan Achenbach, MD
SGLT2 inhibitor benefits patients with HFpEF by reducing clinically meaningful CV events
SGLT2 inhibitor benefits patients with HFpEF by reducing clinically meaningful CV events
ESC 2021
SGLT2 inhibitor benefits patients with HFpEF by reducing clinically meaningful CV events
- Prof. Stefan Anker, MD, PhD